TCRT June 2008
No. 3 (p 155-268)
Glioblastoma Multiforme Treatment
Present Trend in the Primary Treatment of Aggressive Malignant Glioma: Glioblastoma Multiforme (p. 241-248)
The standard treatment for glioblastoma multiforme is surgery, radiation, and chemotherapy. Yet this aggressive therapy has only a modest effect on survival with most patients surviving less than 1 year after diagnosis. This poor prognosis has lead scientists to seek alternative molecular approaches for the treatment of glioblastoma multiforme. Among these, gene therapy, vaccine therapy, and immunotherapy are all approaches that are currently being investigated. While these molecular approaches may not herald an immediate change in the prognosis of these aggressive tumors, combining them with existing approaches may bring some progress in the standard of care. This paper reviews current treatments and several newer therapies in preclinical and early clinical studies.
Key words: Surgery; Radiotherapy; Chemotherapy; Immunotherapy; and Targeting agent.
Tariq Parvez, M.D.
Medical Director II Oncology
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA